tiprankstipranks
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market
ARDS
Aridis Pharmaceuticals
RESEARCH TOOLSreports
Want to see ARDS full AI Analyst Report?

Aridis Pharmaceuticals (ARDS) Income Statement

205 Followers

Aridis Pharmaceuticals Income Statement

Last quarter (Q3 2023), Aridis Pharmaceuticals's total revenue was $417.00K, an increase of Infinity% from the same quarter last year. In Q3, Aridis Pharmaceuticals's net income was $-83.00K. See Aridis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Mar 22Dec 20Mar 20Dec 18
Total Revenue
$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Gross Profit
$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Operating Expenses
$ 29.99M$ 43.71M$ 23.40M$ 30.11M$ 26.87M
Depreciation and Amortization
$ 487.00K$ -722.00K$ 337.00K$ 338.00K$ 283.00K
EBITDA
$ -29.51M$ -44.43M$ -22.06M$ -28.75M$ -23.83M
Operating Income
$ -29.99M$ -43.71M$ -22.40M$ -29.09M$ -24.12M
Other Income/Expenses
$ -378.00K$ 0.00$ 68.00K$ -594.00K$ 2.01M
Pretax Income
$ -30.37M$ -43.19M$ -22.33M$ -29.68M$ -22.11M
Net Income
$ -30.75M$ -42.28M$ -22.33M$ -29.68M$ -22.11M
Per Share Metrics
Basic EPS
$ -1.64$ -3.44$ -2.44$ -3.43$ -7.02
Diluted EPS
$ -1.64$ -3.44$ -2.44$ -3.43$ -7.02
Weighted Average Shares Outstanding
 18.78M 12.29M 9.17M 8.46M 3.15M
Weighted Average Shares Outstanding (Diluted)
 18.78M 12.29M 9.17M 8.46M 3.15M
Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History